- Home
- ATHA vs SLNH Comparison
ATHA vs SLNH Comparison
Compare ATHA & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- SLNH
- Stock Information
- Founded
- ATHA 2011
- SLNH 1961
- Country
- ATHA United States
- SLNH United States
- Employees
- ATHA N/A
- SLNH N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- SLNH EDP Services
- Sector
- ATHA Health Care
- SLNH Technology
- Exchange
- ATHA Nasdaq
- SLNH Nasdaq
- Market Cap
- ATHA 16.1M
- SLNH 15.5M
- IPO Year
- ATHA 2020
- SLNH N/A
- Fundamental
- Price
- ATHA $4.11
- SLNH $3.05
- Analyst Decision
- ATHA
- SLNH Hold
- Analyst Count
- ATHA 0
- SLNH 1
- Target Price
- ATHA N/A
- SLNH N/A
- AVG Volume (30 Days)
- ATHA 27.3K
- SLNH 14.1M
- Earning Date
- ATHA 11-06-2025
- SLNH 11-14-2025
- Dividend Yield
- ATHA N/A
- SLNH N/A
- EPS Growth
- ATHA N/A
- SLNH N/A
- EPS
- ATHA N/A
- SLNH N/A
- Revenue
- ATHA N/A
- SLNH $27,891,000.00
- Revenue This Year
- ATHA N/A
- SLNH N/A
- Revenue Next Year
- ATHA N/A
- SLNH $42.68
- P/E Ratio
- ATHA N/A
- SLNH N/A
- Revenue Growth
- ATHA N/A
- SLNH N/A
- 52 Week Low
- ATHA $2.20
- SLNH $0.36
- 52 Week High
- ATHA $8.26
- SLNH $5.14
- Technical
- Relative Strength Index (RSI)
- ATHA 59.40
- SLNH 50.76
- Support Level
- ATHA $3.95
- SLNH $2.94
- Resistance Level
- ATHA $4.50
- SLNH $4.04
- Average True Range (ATR)
- ATHA 0.24
- SLNH 0.63
- MACD
- ATHA -0.05
- SLNH -0.10
- Stochastic Oscillator
- ATHA 55.81
- SLNH 16.54
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.